NEW YORK (GenomeWeb) – Thermo Fisher Scientific today reported a 1 percent year-over-year decline in revenues for the third quarter but still beat the average Wall Street estimate on the top and bottom lines. 

For the three months ended Sept. 26, the company reported total revenues of $4.12 billion, down from $4.17 billion in the year-ago quarter but still above the analysts' average estimate of $4.10 billion. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers report that deleting one gene from butterflies affects their wing coloration patterns, according to the Washington Post.

The Seattle Times writes that pharmacogenomics testing can help choose medications that may work best for people with depression.

In PNAS this week: genome sequencing of weevil symbionts, retinoid X receptor deletion in lung cancer metastasis, and more.

Sequencing could help combat foodborne illnesses, according to a blog post by Food and Drug Administration officials.